ASET Therapeutics, Inc

ASET Therapeutics Inc, discovers and develops therapeutics that selectively block mutant oncoproteins for the treatment of cancer.  Our vision is to provide a precision medicine solution that enables oncologists to screen cancer patients for tumors driven by a specific oncogenic lesion and to prescribe patient selective treatments.

Contact Information:

Elizabeth Buck, Ph.D., Founder & CSO
Phone: 631-944-2878